Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 408

1.

Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.

Li ST, Tancredi DJ.

Pediatrics. 2010 Jan;125(1):26-33. doi: 10.1542/peds.2009-0184. Erratum in: Pediatrics. 2010 Feb;125(2):415.

PMID:
19948570
2.

Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.

Ho PL, Chiu SS, Chow FK, Mak GC, Lau YL.

Vaccine. 2007 Sep 28;25(39-40):6837-41.

PMID:
17714837
3.

[Bacteremic pneumococcal pneumonia].

Pineda Solas V, Pérez Benito A, Domingo Puiggros M, Larramona Carrera H, Segura Porta F, Fontanals Aymerich D.

An Esp Pediatr. 2002 Nov;57(5):408-13. Spanish.

PMID:
12467543
4.

The epidemiology of invasive pneumococcal disease in children in Far North Queensland.

Fagan RL, Hanna JN, Messer RD, Brookes DL, Murphy DM.

J Paediatr Child Health. 2001 Dec;37(6):571-5.

PMID:
11903838
5.

Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.

Lindstrand A, Bennet R, Galanis I, Blennow M, Ask LS, Dennison SH, Rinder MR, Eriksson M, Henriques-Normark B, Ortqvist A, Alfvén T.

Pediatrics. 2014 Dec;134(6):e1528-36. doi: 10.1542/peds.2013-4177.

6.

Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.

Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO.

Pediatr Infect Dis J. 2006 Mar;25(3):250-4.

PMID:
16511389
7.

Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.

Hendrickson DJ, Blumberg DA, Joad JP, Jhawar S, McDonald RJ.

Pediatr Infect Dis J. 2008 Nov;27(11):1030-2. doi: 10.1097/INF.0b013e31817e5188.

PMID:
18845981
8.

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, Noyes J, Lewis E, Ray P, Lee J, Hackell J.

Pediatr Infect Dis J. 2002 Sep;21(9):810-5.

PMID:
12352800
9.

Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.

Haddy RI, Perry K, Chacko CE, Helton WB, Bowling MG, Looney SW, Buck GE.

Pediatr Infect Dis J. 2005 Apr;24(4):320-3.

PMID:
15818291
10.

Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine.

Strachan RE, Snelling TL, Jaffé A.

Bull World Health Organ. 2013 Mar 1;91(3):167-73. doi: 10.2471/BLT.12.109231. Erratum in: Bull World Health Organ. 2013 May 1;91(5):388.

11.

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B.

Pediatr Infect Dis J. 2004 Jun;23(6):485-9.

PMID:
15194827
12.

Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children.

von Kries R, Hermann M, Hachmeister A, Siedler A, Schmitt HJ, Al-Lahham A, Reinert RR.

Pediatr Infect Dis J. 2002 Nov;21(11):1017-23.

PMID:
12442022
13.

Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.

Hsu K, Pelton S, Karumuri S, Heisey-Grove D, Klein J; Massachusetts Department of Public Health Epidemiologists..

Pediatr Infect Dis J. 2005 Jan;24(1):17-23.

PMID:
15665705
14.

Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine--United States, 1997-2006.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):1-4.

15.

The changing face of pleural empyemas in children: epidemiology and management.

Schultz KD, Fan LL, Pinsky J, Ochoa L, Smith EO, Kaplan SL, Brandt ML.

Pediatrics. 2004 Jun;113(6):1735-40.

PMID:
15173499
17.

Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.

Adamkiewicz TV, Silk BJ, Howgate J, Baughman W, Strayhorn G, Sullivan K, Farley MM.

Pediatrics. 2008 Mar;121(3):562-9. doi: 10.1542/peds.2007-0018.

PMID:
18310206
18.

The cost-effectiveness of pneumococcal conjugate vaccination in Australia.

Butler JR, McIntyre P, MacIntyre CR, Gilmour R, Howarth AL, Sander B.

Vaccine. 2004 Mar 12;22(9-10):1138-49.

PMID:
15003641
19.

Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):144-8.

20.

Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.

Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF.

Pediatrics. 2009 Jun;123(6):e1103-10. doi: 10.1542/peds.2008-3422.

PMID:
19482744
Items per page

Supplemental Content

Support Center